National Research Laboratory for Mitochondrial Signaling, Department of Physiology, Department of Health Sciences and Technology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center, Inje University College of Medicine, Bokji-ro 75, Busanjin-gu, Busan, 47392, South Korea.
Department of Integrated Biomedical Science, Inje University College of Medicine, Busan, South Korea.
Pflugers Arch. 2018 Jul;470(7):995-1016. doi: 10.1007/s00424-018-2136-x. Epub 2018 Mar 13.
Alternative splicing (AS) of protein-coding messenger RNAs is an essential regulatory mechanism in eukaryotic gene expression that controls the proper function of proteins. It is also implicated in the physiological regulation of mitochondria and various ion channels. Considering that mis-splicing can result in various human diseases by modifying or abrogating important physiological protein functions, a fine-tuned balance of AS is essential for human health. Accumulated data highlight the importance of alternatively spliced isoforms in various diseases, including neurodegenerative disorders, cancer, immune and infectious diseases, cardiovascular diseases, and metabolic conditions. However, basic understanding of disease mechanisms and development of clinical applications still require the integration and interpretation of physiological roles of AS. This review discusses the roles of AS in health and various diseases, while highlighting potential AS-targeting therapeutic applications.
蛋白质编码信使 RNA 的可变剪接(AS)是真核基因表达中一种重要的调控机制,可控制蛋白质的正常功能。它还与线粒体和各种离子通道的生理调节有关。考虑到通过改变或消除重要的生理蛋白功能,剪接错误可能导致各种人类疾病,因此 AS 的精细平衡对于人类健康至关重要。累积的数据强调了可变剪接异构体在各种疾病中的重要性,包括神经退行性疾病、癌症、免疫和传染病、心血管疾病和代谢疾病。然而,对疾病机制的基本理解和临床应用的发展仍需要整合和解释 AS 的生理作用。这篇综述讨论了 AS 在健康和各种疾病中的作用,同时强调了潜在的 AS 靶向治疗应用。